Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TheraCal PT Versus Formocresol in Primary Molar Pulpotomies
NCT07864181Phase 2Completed
- Sponsor
- Hama University
- Start
- Jan 2024
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
A Phase 2 trial of TheraCal in reversible pulpitis, sponsored by Hama University. Started Jan 2024; status: completed.
02
Drugs
TheraCal
03
Conditions
reversible pulpitis
Beyond the preview
Go deeper on NCT07864181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07864181.